Literature DB >> 20232448

Susceptibility to invasive bacterial infections in children with sickle cell disease.

Anna J Battersby1, Huxley H M Knox-Macaulay, Enitan D Carrol.   

Abstract

Individuals with sickle cell disease (SCD) demonstrate an increased susceptibility to invasive bacterial infections (IBI). The most common organisms causing IBI are Streptococcus pneumoniae, nontyphi Salmonella species and Haemophilus influenzae type b (Hib). IBI are the most common causes of death in children below 5 years of age with SCD. Increased susceptibility to IBI is because of several factors including dysfunctional antibody production and opsonophagocytosis as well as defective splenic clearance. Early diagnosis of Hib and pneumococcal infections combined with antibiotic prophylaxis and immunization programs, could lead to significant improvements in mortality, especially in Africa. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232448     DOI: 10.1002/pbc.22461

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  Tuberculosis in children with sickle cell anaemia: a retrospective study in French tertiary care centres.

Authors:  Nina Droz; Agathe De Lauzanne; Laurent Holvoet; Florence Missud; Malika Benkerrou; Valentine Brousse; Marie-Hélène Odièvre; Albert Faye; Berengere Koehl
Journal:  Eur J Pediatr       Date:  2017-04-11       Impact factor: 3.183

Review 2.  Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

3.  Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease.

Authors:  Marianne E Yee; Nitya Bakshi; Sara H Graciaa; Peter A Lane; Robert C Jerris; Yun F Wang; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2019-02-05       Impact factor: 3.167

4.  Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.

Authors:  Carol M Kao; Kristina Lai; John M McAteer; Mohnd Elmontser; Elizabeth M Quincer; Marianne E M Yee; Ashley Tippet; Robert C Jerris; Peter A Lane; Evan J Anderson; Nitya Bakshi; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2020-05-29       Impact factor: 3.167

5.  Preventive Care Delivery to Young Children With Sickle Cell Disease.

Authors:  David G Bundy; John Muschelli; Gwendolyn D Clemens; John J Strouse; Richard E Thompson; James F Casella; Marlene R Miller
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

6.  Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.

Authors:  Elsa Maksoud; Berengere Koehl; Aude Facchin; Phuong Ha; Wei Zhao; Florentia Kaguelidou; Malika Benkerrou; Patricia Mariani; Albert Faye; Mathie Lorrot; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.

Authors:  Steven M Szczepanek; Jeffrey T McNamara; Eric R Secor; Prabitha Natarajan; Linda A Guernsey; Lauren A Miller; Enrique Ballesteros; Evan Jellison; Roger S Thrall; Biree Andemariam
Journal:  Am J Pathol       Date:  2012-09-19       Impact factor: 4.307

8.  Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Authors:  Amanda B Payne; Ruth Link-Gelles; Ijeoma Azonobi; W Craig Hooper; Bernard W Beall; James H Jorgensen; Billie Juni; Matthew Moore
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

Review 9.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

10.  Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Authors:  Robert Carter; Joshua Wolf; Tim van Opijnen; Patricia M Flynn; Elaine I Tuomanen; Jason W Rosch; Martha Muller; Caroline Obert; Corinna Burnham; Beth Mann; Yimei Li; Randall T Hayden; Tamara Pestina; Derek Persons; Andrew Camilli
Journal:  Cell Host Microbe       Date:  2014-05-14       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.